When was GLEAMER acquired by SUPERNOVA INVEST / HEAL CAPITAL?

GLEAMER was acquired by SUPERNOVA INVEST / HEAL CAPITAL in 2023.

What was the revenue of GLEAMER at the time of the deal?

The revenue of GLEAMER at the time of the deal is estimated to be in the range of 5M - 25M EUR.

How is the data for the GLEAMER acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the GLEAMER deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://capitalfinance.lesechos.fr/deals/sortie/la-medtech-gleamer-passe-sous-pavillon-americain-pour-230-meur-2218889

← DATABASE

Home Database Healthcare & PharmaGLEAMER

06/2023

GLEAMER acquired by SUPERNOVA INVEST / HEAL CAPITAL

FRANCE Healthcare Services / Health Tech REV 5M - 25M EUR

Context

Gleamer raised €27 million in Series B funding to broaden its AI solution portfolio and accelerate global commercial development. The strategic plan involves expanding the software suite to include CT scans and mammography, aiming to cover 70% of radiologists' daily diagnostic needs. A significant portion of the capital is earmarked for strengthening commercial and technical teams in Europe and the United States, as well as deepening strategic partnerships with global medical imaging equipment manufacturers (OEMs).

GLEAMER, which reported an EBITDA margin of in 2023, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Healthcare & Pharma sector (15.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Gleamer is a leading French MedTech company specializing in artificial intelligence for medical imaging. Its "Copilot" platform provides automated diagnostic assistance for radiologists across multiple modalities, including X-ray, Mammography, and MRI. Prior to this acquisition, Gleamer consolidated the market by acquiring Pixyl and Caerus Medical in 2025, expanding its expertise into neuro and lumbar MRI. The company serves over 700 clients in 44 countries, with its solutions supporting over 25 clinical indications.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2023

2022

Other operations with GLEAMER

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
03/2026	RADNET	GLEAMER	FRANCE	Health Tech

REFERENCES

Revenue range: 5M - 25M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of GLEAMER by SUPERNOVA INVEST / HEAL CAPITAL are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: gleamer

Acquirer: supernova invest